195 related articles for article (PubMed ID: 9914436)
1. Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations.
Wegiel J; Wisniewski HM; Dziewiatkowski J; Badmajew E; Tarnawski M; Reisberg B; Mlodzik B; De Leon MJ; Miller DC
Brain Res; 1999 Feb; 818(1):41-50. PubMed ID: 9914436
[TBL] [Abstract][Full Text] [Related]
2. Stereological quantification of the cerebellum in patients with Alzheimer's disease.
Andersen K; Andersen BB; Pakkenberg B
Neurobiol Aging; 2012 Jan; 33(1):197.e11-20. PubMed ID: 20728248
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes.
Sjöbeck M; Englund E
Dement Geriatr Cogn Disord; 2001; 12(3):211-8. PubMed ID: 11244215
[TBL] [Abstract][Full Text] [Related]
4. Canine cognitive dysfunction and the cerebellum: acetylcholinesterase reduction, neuronal and glial changes.
Pugliese M; Gangitano C; Ceccariglia S; Carrasco JL; Del Fà A; Rodríguez MJ; Michetti F; Mascort J; Mahy N
Brain Res; 2007 Mar; 1139():85-94. PubMed ID: 17292335
[TBL] [Abstract][Full Text] [Related]
5. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease.
Roher AE; Kuo YM; Esh C; Knebel C; Weiss N; Kalback W; Luehrs DC; Childress JL; Beach TG; Weller RO; Kokjohn TA
Mol Med; 2003; 9(3-4):112-22. PubMed ID: 12865947
[TBL] [Abstract][Full Text] [Related]
6. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
[TBL] [Abstract][Full Text] [Related]
7. Juvenile Alzheimer's disease with cerebellar involvement.
Vakili ST; Muller J
Arch Pathol Lab Med; 1987 May; 111(5):480-2. PubMed ID: 3566478
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: amyloid plaques in the cerebellum.
Braak H; Braak E; Bohl J; Lang W
J Neurol Sci; 1989 Nov; 93(2-3):277-87. PubMed ID: 2556503
[TBL] [Abstract][Full Text] [Related]
9. Primary degeneration of the granular layer of the cerebellum. A study of 14 patients and review of the literature.
Pascual-Castroviejo I; Gutierrez M; Morales C; Gonzalez-Mediero I; Martínez-Bermejo A; Pascual-Pascual SI
Neuropediatrics; 1994 Aug; 25(4):183-90. PubMed ID: 7824090
[TBL] [Abstract][Full Text] [Related]
10. Purkinje Cells Pathology in Alzheimer's Disease.
Mavroudis I; Petridis F; Kazis D; Njau SN; Costa V; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2019; 34(7-8):439-449. PubMed ID: 31256608
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar pathology in Alzheimer's disease.
Mavroudis I
Hell J Nucl Med; 2019; 22 Suppl():174-179. PubMed ID: 30877735
[TBL] [Abstract][Full Text] [Related]
12. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
Joachim CL; Morris JH; Selkoe DJ
Am J Pathol; 1989 Aug; 135(2):309-19. PubMed ID: 2675616
[TBL] [Abstract][Full Text] [Related]
13. The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
Gallo M; Frangipane F; Cupidi C; De Bartolo M; Turone S; Ferrari C; Nacmias B; Grimaldi G; Laganà V; Colao R; Bernardi L; Anfossi M; Conidi ME; Vasso F; Curcio SAM; Mirabelli M; Smirne N; Torchia G; Muraca MG; Puccio G; Di Lorenzo R; Piccininni M; Tedde A; Maletta RG; Sorbi S; Bruni AC
Neurobiol Aging; 2017 Aug; 56():213.e7-213.e12. PubMed ID: 28532646
[TBL] [Abstract][Full Text] [Related]
14. Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease.
Olazarán J; Hernández-Tamames JA; Molina E; García-Polo P; Dobato JL; Álvarez-Linera J; Martínez-Martín P;
J Alzheimers Dis; 2013; 33(2):495-505. PubMed ID: 23011219
[TBL] [Abstract][Full Text] [Related]
15. Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation.
Fukutani Y; Cairns NJ; Rossor MN; Lantos PL
J Neurol Sci; 1997 Aug; 149(2):177-84. PubMed ID: 9171327
[TBL] [Abstract][Full Text] [Related]
16. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
18. Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.
Chauhan NB; Lee JM; Siegel GJ
J Mol Neurosci; 1997 Dec; 9(3):151-66. PubMed ID: 9481617
[TBL] [Abstract][Full Text] [Related]
19. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor proteins in the cerebellar cortex of Alzheimer's disease patients devoid of cerebellar beta-amyloid deposits: immunocytochemical study of five cases.
Toledano A; Alvarez MI; Rivas L; Lacruz C; Martínez-Rodríguez R
J Neural Transm (Vienna); 1999; 106(11-12):1151-69. PubMed ID: 10651111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
